MD3942C2 - Iron and cobalt complexes with 2-furoic acid possessing antituberculous properties - Google Patents

Iron and cobalt complexes with 2-furoic acid possessing antituberculous properties

Info

Publication number
MD3942C2
MD3942C2 MDA20090003A MD20090003A MD3942C2 MD 3942 C2 MD3942 C2 MD 3942C2 MD A20090003 A MDA20090003 A MD A20090003A MD 20090003 A MD20090003 A MD 20090003A MD 3942 C2 MD3942 C2 MD 3942C2
Authority
MD
Moldova
Prior art keywords
iron
antituberculous
properties
furoic acid
cobalt complexes
Prior art date
Application number
MDA20090003A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3942F1 (en
Inventor
Сильвия МЕЛЬНИК
Денис ПРОДИУС
Серджиу ШОВА
Константин ТУРТЭ
Original Assignee
Институт Химии Академии Наук Молдовы
Государственный Университет Молд0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Химии Академии Наук Молдовы, Государственный Университет Молд0 filed Critical Институт Химии Академии Наук Молдовы
Priority to MDA20090003A priority Critical patent/MD3942C2/en
Publication of MD3942F1 publication Critical patent/MD3942F1/en
Publication of MD3942C2 publication Critical patent/MD3942C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to iron and cobalt complexes with 2-furoic acid, with antituberculous activity.Summary of the invention consists in the synthesis of heteronuclear compounds (I-III), of formula:[Fe2CoO(C4H3OCOO)6(L1)(L2)2], wheremanifesting Mycobacterium tuberculosis culture growth inhibition properties.
MDA20090003A 2009-01-22 2009-01-22 Iron and cobalt complexes with 2-furoic acid possessing antituberculous properties MD3942C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20090003A MD3942C2 (en) 2009-01-22 2009-01-22 Iron and cobalt complexes with 2-furoic acid possessing antituberculous properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20090003A MD3942C2 (en) 2009-01-22 2009-01-22 Iron and cobalt complexes with 2-furoic acid possessing antituberculous properties

Publications (2)

Publication Number Publication Date
MD3942F1 MD3942F1 (en) 2009-07-31
MD3942C2 true MD3942C2 (en) 2010-02-28

Family

ID=40941132

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20090003A MD3942C2 (en) 2009-01-22 2009-01-22 Iron and cobalt complexes with 2-furoic acid possessing antituberculous properties

Country Status (1)

Country Link
MD (1) MD3942C2 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1128860A (en) * 1977-04-20 1982-08-03 Gunther Wilhelm Peptide complexes of dna-containing organisms
MD346G2 (en) * 1995-04-12 1996-09-30 Государственный Университет Молд0 Picoliden-4-isonicotino-yl-hydrazone dyhidrate with tuberculostatic activity
MD675C2 (en) * 1995-03-06 1998-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова The cobalt's complexes with antimicrobic activity and process for manufacturing of them
US20020068761A1 (en) * 1999-10-04 2002-06-06 Bernstein Lawrence R. Gallium complexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
MD2146C2 (en) * 2001-07-12 2003-10-31 Государственный Университет Молд0 Dielectric materials on base of heteronuclear coordinative combinations of cobalt (III) and bismuth (III)
MD2786G2 (en) * 2004-05-11 2006-02-28 Государственный Университет Молд0 Inhibitors of human myeloid leukemia on base of heteronuclear coordinative compounds of cobalt(III) and bismuth(III)
ZA200600783B (en) * 2004-02-04 2007-02-28 Maneesh Pharmaceuticals Pvt Lt Oral cyclodextrin complexes of anti-tuberculosis drug
CA2647096A1 (en) * 2006-03-23 2007-09-27 Centre National De La Recherche Scientifique Complexes of nadp with the protein maba of mycobacterium tuberculosis or with mutants thereof, and their uses for designing and screening antibiotics
CA2652454A1 (en) * 2006-05-24 2007-12-06 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of mycobacterium tuberculosis complex organisms in a test sample

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1128860A (en) * 1977-04-20 1982-08-03 Gunther Wilhelm Peptide complexes of dna-containing organisms
MD675C2 (en) * 1995-03-06 1998-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова The cobalt's complexes with antimicrobic activity and process for manufacturing of them
MD346G2 (en) * 1995-04-12 1996-09-30 Государственный Университет Молд0 Picoliden-4-isonicotino-yl-hydrazone dyhidrate with tuberculostatic activity
US20020068761A1 (en) * 1999-10-04 2002-06-06 Bernstein Lawrence R. Gallium complexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
MD2146C2 (en) * 2001-07-12 2003-10-31 Государственный Университет Молд0 Dielectric materials on base of heteronuclear coordinative combinations of cobalt (III) and bismuth (III)
WO2003053347A2 (en) * 2001-12-20 2003-07-03 Bernstein Lawrence R Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
ZA200600783B (en) * 2004-02-04 2007-02-28 Maneesh Pharmaceuticals Pvt Lt Oral cyclodextrin complexes of anti-tuberculosis drug
MD2786G2 (en) * 2004-05-11 2006-02-28 Государственный Университет Молд0 Inhibitors of human myeloid leukemia on base of heteronuclear coordinative compounds of cobalt(III) and bismuth(III)
CA2647096A1 (en) * 2006-03-23 2007-09-27 Centre National De La Recherche Scientifique Complexes of nadp with the protein maba of mycobacterium tuberculosis or with mutants thereof, and their uses for designing and screening antibiotics
CA2652454A1 (en) * 2006-05-24 2007-12-06 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of mycobacterium tuberculosis complex organisms in a test sample

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Bottari B., Maccari R., Monforte F., Ottana R., Rotondo E., Vigorita M. G. Bioorg. Med. Chem. Lett., V. 10, (2000), p. 657. *
Bottari, B., Maccari, R., Monforte, F., Ottana, R., Rotondo, E., Vigorita, M. G. Bioorg. Med. Chem. Lett., V. 10, 2000, pp. 657. *
Khasnobis S., Escuyer V. E., Chatterjee D. Expert Opin. Ther. Targets 6, (2002), pp. 21. *
Khasnobis, S., Escuyer, V. E., Chatterjee, D. Expert Opin. Ther. Targets 6, 2002, pp. 21. *

Also Published As

Publication number Publication date
MD3942F1 (en) 2009-07-31

Similar Documents

Publication Publication Date Title
PH12015500891A1 (en) A stable iron oligosaccharide compound
MX2013004491A (en) Boronates as arginase inhibitors.
TW200612958A (en) Substituted imidazole derivatives
MX2009007713A (en) Pyridazine derivatives, processes for their preparation and their use as fungicides.
MX2012000414A (en) Pyridin-4-yl derivatives.
MY150538A (en) Process for the manufacture of dihydropteridinones
EP1604665A4 (en) C-kit kinase inhibitor
MX2010003394A (en) Bicyclic ?“-amino acid derivative.
NZ580226A (en) Dimer compounds as inhibitors of iap
PH12013502369A1 (en) Diazacarbazoles and methods of use
MY165103A (en) Recombinant microorganisms and methods of use thereof
MX2009013341A (en) 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives.
WO2009122436A3 (en) An improved process for the preparation of morphinane analogues
MY148288A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
TW200617006A (en) New process for the manufacture of tiotropium salts
MX349550B (en) 1, 7 - diazacarbazoles and their use in the treatment of cancer.
TW200740777A (en) Perfluoroalkyl-containing complexes, process for their production as well as their use
GEP20135960B (en) New method of synthesis of ivabradine and pharmaceutically acceptable acid-additive salts thereof
NZ597483A (en) N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
IN2012DN00954A (en)
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
TW200738704A (en) New process for the production of tiotropium salts
JO2781B1 (en) New Process For The Synthesis Of Ivabradine And Addition Salts Thereof With A Pharmaceutically Acceptable Acid
WO2008110774A3 (en) Pentalenes
MX2010001938A (en) Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)p yrimidine-based compounds.

Legal Events

Date Code Title Description
FG4A Patent for invention issued
TK4A Erratum in official gazette in regard to patent for invention

Free format text: RECTIFICATION IN INID 13

KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees